Received Dec 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
non small cell lung cancer; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NON-SMALL CELL LUNG CANCER (medically significant), outcome "unknown", described as "non small cell lung cancer". Clinical course: Consumer reported that her husband has non small cell lung cancer from getting the Pfizer covid shot. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.